DOI QR코드

DOI QR Code

Disseminated Cytomegalovirus Infection and Protein Losing Enteropathy as Presenting Feature of Pediatric Patient with Crohn's Disease

  • Cakir, Murat (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Karadeniz Technical University) ;
  • Ersoz, Safak (Department of Pathology, Faculty of Medicine, Karadeniz Technical University) ;
  • Akbulut, Ulas Emre (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Karadeniz Technical University)
  • Received : 2014.11.11
  • Accepted : 2015.01.09
  • Published : 2015.03.30

Abstract

We report a pediatric patient admitted with abdominal pain, diffuse lower extremity edema and watery diarrhea for two months. Laboratory findings including complete blood count, serum albumin, lipid and immunoglobulin levels were compatible with protein losing enteropathy. Colonoscopic examination revealed diffuse ulcers with smooth raised edge (like "punched out holes") in the colon and terminal ileum. Histopathological examination showed active colitis, ulcerations and inclusion bodies. Immunostaining for cytomegalovirus was positive. Despite supportive management, antiviral therapy, the clinical condition of the patient worsened and developed disseminated cytomegalovirus infection and the patient died. Protein losing enteropathy and disseminated cytomegalovirus infection a presenting of feature in steroid-naive patient with inflammatory bowel disease is very rare. Hypogammaglobulinemia associated with protein losing enteropathy in Crohn's disease may predispose the cytomegalovirus infection in previously healthy children.

Keywords

References

  1. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009;22:76-98. https://doi.org/10.1128/CMR.00034-08
  2. Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010;55:1059-65. https://doi.org/10.1007/s10620-010-1126-4
  3. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis 2010;16:1620-7. https://doi.org/10.1002/ibd.21275
  4. Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010;105:43-9. https://doi.org/10.1038/ajg.2009.561
  5. Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol 2008;197:65-73. https://doi.org/10.1007/s00430-007-0066-x
  6. Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007;13:1516-21. https://doi.org/10.1002/ibd.20253
  7. Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007;102: 331-7. https://doi.org/10.1111/j.1572-0241.2006.00989.x
  8. Berk T, Gordon SJ, Choi HY, Cooper HS. Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol 1985;80:355-60.
  9. Pfau P, Kochman ML, Furth EE, Lichtenstein GR. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 2001; 96:895-9. https://doi.org/10.1111/j.1572-0241.2001.03672.x
  10. Ghidini B, Bellaiche M, Berrebi D, Viala J, Hugot JP, Mougenot JF, et al. Cytomegalovirus colitis in children with inflammatory bowel disease. Gut 2006;55:582-3. https://doi.org/10.1136/gut.2005.086736
  11. Inoue K, Wakabayashi N, Fukumoto K, Yamada S, Bito N, Yoshida N, et al. Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naive ulcerative colitis. Intern Med 2012;51:2739-43. https://doi.org/10.2169/internalmedicine.51.8145
  12. Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, et al. Protein-losing enteropathy in Crohn's disease. Acta Gastroenterol Belg 2006;69: 384-9.
  13. Sferra TJ, Pawel BR, Qualman SJ, Li BU. Menetrier disease of childhood: role of cytomegalovirus and transforming growth factor alpha. J Pediatr 1996;128:213-9. https://doi.org/10.1016/S0022-3476(96)70392-X
  14. Orvar K, Murray J, Carmen G, Conklin J. Cytomegalovirus infection associated with onset of in flammatory bowel disease. Dig Dis Sci 1993;38:2307-10. https://doi.org/10.1007/BF01299914
  15. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van Der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989; 48:469-72. https://doi.org/10.1097/00007890-198909000-00024
  16. Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008;14:1373-9. https://doi.org/10.1002/ibd.20498
  17. Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, et al; European Crohn's and Colitis Organization; Porto IBD Working Group, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011;106:574-88. https://doi.org/10.1038/ajg.2010.481

Cited by

  1. Protein-losing enteropathy vol.89, pp.2, 2015, https://doi.org/10.17116/terarkh20178924-9
  2. CMV Infection in Pediatric IBD vol.20, pp.4, 2018, https://doi.org/10.1007/s11894-018-0617-x
  3. Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases vol.30, pp.3, 2020, https://doi.org/10.1017/s1047951120000049